Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Huahui Yang, MS
MicuRx Pharmaceuticals Inc, China
Disclosure(s): MicuRx Pharmaceuticals Inc: Employee
Poster(s):
1699 - Efficacy and Safety by BMI Category and Gender in Contezolid and Contezolid Acefosamil Phase 2 and Phase 3 Skin Infection Clinical Trials
Saturday, October 22, 2022
12:15 PM – 1:30 PM
US ET
1700 - Efficacy and Safety in Subjects with Renal Impairment in Contezolid and Contezolid Acefosamil Phase 2 and Phase 3 Skin Infection Clinical Trials
Saturday, October 22, 2022
12:15 PM – 1:30 PM
US ET
1701 - Pharmacokinetics in Subjects with Renal Impairment in a Contezolid Complicated Skin and Soft Tissue Infection Phase 3 Clinical Trial
Saturday, October 22, 2022
12:15 PM – 1:30 PM
US ET
1702 - Platelet Counts in Contezolid Complicated Skin and Soft Tissue Infection Phase 2 and Phase 3 Clinical Trials
Saturday, October 22, 2022
12:15 PM – 1:30 PM
US ET
.png)
.png)